⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12273503 | 0.88 | — | — | |
| SCHEMBL42723 | 0.88 | — | — | |
| SCHEMBL8073182 | 0.79 | — | — | |
| SCHEMBL2146142 | 0.79 | — | — | |
| SCHEMBL4257309 | 0.76 | — | — | |
| SCHEMBL9154492 | 0.74 | — | — | |
| SCHEMBL157843 | 0.73 | — | — | |
| SCHEMBL10936472 | 0.73 | — | — | |
| SCHEMBL4329971 | 0.73 | — | — | |
| SCHEMBL187192 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1330 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240140919-A1 | MODULATORS OF EUKARYOTIC INITIATION FACTOR 2 | DENALI THERAPEUTICS INC. | 2024-05-02 | — | — | US | claimed |
| US-11970485-B2 | RET kinase inhibitors | ELI LILLY AND COMPANY (US) | 2024-04-30 | — | — | US | claimed |
| WO-2024064178-A1 | HEXAHYDRO-2H-PYRIDO[2,1-A]ISOQUINOLINE VMAT2 INHIBITORS AND METHODS OF USE | NEUROCRINE BIOSCIENCES, INC. (US) | 2024-03-28 | — | — | WO | claimed |
| US-20230339904-A1 | ISOINDOLINONES, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | BIOTHERYX, INC. | 2023-10-26 | — | — | US | claimed |
| EP-4240738-A1 | PYRAZOLE DERIVATIVES AS RET KINASE INHIBITORS | Eli Lilly and Company (US) | 2023-09-13 | — | — | EP | claimed |
| US-20230265085-A1 | RET KINASE INHIBITORS | LOXO ONCOLOGY, INC. | 2023-08-24 | — | — | US | claimed |
| CN-111943986-B | Metal complex containing multiple condensed heterocyclic structure ligands | 夏禾科技(江苏)有限公司 | 2023-08-15 | — | — | CN | claimed |
| US-20230250072-A1 | MODULATORS OF EUKARYOTIC INITIATION FACTOR 2 | DENALI THERAPEUTICS INC. | 2023-08-10 | — | — | US | claimed |
| CN-116438179-A | Pyrazole derivatives as RET kinase inhibitors | 伊莱利利公司 | 2023-07-14 | — | — | CN | claimed |
| US-11697647-B2 | RET kinase inhibitors | ELI LILLY AND COMPANY (US) | 2023-07-11 | — | — | US | claimed |
| CN-106543194-A | Narciscycline derivative, preparation thereof and application thereof in preparing antitumor drugs | 孙青* | 2017-03-29 | — | — | CN | claimed |
| WO-2017013637-A1 | SELECTIVE INHIBITORS OF ALPHA2-CONTAINING ISOFORMS OF NA,K-ATPASE AND USE THEREOF FOR REDUCTION OF INTRAOCULAR PRESSURE | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2017-01-26 | — | — | WO | claimed |
| WO-2017013648-A1 | SELECTIVE INHIBITORS OF Alpha2-CONTAINING ISOFORMS OF Na,K-ATPase AND USE THEREOF FOR REDUCTION OF INTRAOCULAR PRESSURE | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2017-01-26 | — | — | WO | claimed |
| US-9334267-B2 | RAF inhibitor compounds | DECIPHERA PHARMACEUTICALS, LLC (US) | 2016-05-10 | — | — | US | claimed |
| US-20150119392-A1 | RAF INHIBITOR COMPOUNDS | DECIPHERA PHARMACEUTICALS, LLC | 2015-04-30 | — | — | US | claimed |
| WO-2013134252-A1 | 2-AMINO, 6 - PHENYL SUBSTITUTED PYRIDO [2, 3 - D] PYRIMIDINE DERIVATIVES USEFUL AS RAF KINASE INHIBITORS | ELI LILLY AND COMPANY (US) | 2013-09-12 | — | — | WO | claimed |
| CN-1090267-A | Novel 7-(replacement)-8-(replacement)-9-(amino of replacement)-6-demethyl-6-deoxidation tsiklomitsin | AMERICAN CYANAMID CO (US) | 1994-08-03 | — | — | CN | claimed |
| EP-0239357-B1 | PROCESS FOR PREPARING MONOSODIUM PHOSPHOENOLPYRUVATE AND USE OF THE SAME AS VISCERAL FUNCTION IMPROVER | UBE INDUSTRIES, LTD. (JP) | 1991-10-16 | — | — | EP | claimed |
| US-4874882-A | HYDROLYSIS OF MONOSODIUM MONOSUBSTITUTED PHOSPHOENOLPYRUVATE | UBE INDUSTRIES, LTD. (JP) | 1989-10-17 | — | — | US | claimed |
| EP-0239357-A2 | Process for preparing monosodium phosphoenolpyruvate and use of the same as visceral function improver | UBE INDUSTRIES, LTD. (JP) | 1987-09-30 | — | — | EP | claimed |